MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
$52,942K
Free Cash flow
-$12,877K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from share issuance
Stock-based compensation expense
Change in fair value of warrant ...
Others
Negative Cash Flow Breakdown
Net loss
Share repurchase
Share issuance costs
Others
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Cash Flow
2026-06-30
2025-06-30
Net loss
-19,302
-46,885
Depreciation and amortization
240
246
Unrealized loss on foreign currency remeasurement
-15
-294
Non-cash expense of eloc commitment
0
-
Stock-based compensation expense
7,559
2,609
Change in fair value of warrant liabilities
620
21,925
Non-cash expense of eloc commitment
-
1,048
Change in fair value of convertible rights
0
-299
Non-cash interest expense
0
302
Loss on extinguishment
0
-1,472
Share of earnings (loss) of joint venture
-37
-
Prepaid expenses and other current assets
-279
189
R&d tax incentive receivable
242
-5,579
Trade and other payables
-2,073
1,385
Net cash used in operating activities
-12,867
-12,513
Purchase of property, plant and equipment
10
8
Investment of joint venture
84
-
Net cash used in investing activities
-94
-8
Proceeds received from facility agreement
0
4,282
Repayment of facility agreement
0
4,459
Proceeds from share issuance
78,667
48,343
Share issuance costs
3,083
747
Warrant issuance costs
284
125
Proceeds from issuance of convertible debt
0
2,779
Cancellation of warrants
0
24,769
Repayment of convertible debt
0
3,795
Debt issuance costs
0
113
Share repurchase
9,397
-
Net cash provided by financing activities
65,903
21,396
Net increase in cash and cash equivalents
52,942
8,875
Cash and cash equivalents at beginning of period
15,039
-
Cash and cash equivalents at end of period
67,711
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
IXHL Cash Flow Sankey Diagram
Sankey diagram visualizing IXHL cash flow for the period
Proceeds from share
issuance
$78,667K
(62.73%↑ Y/Y)
Net cash provided by
financing activities
$65,903K
(208.02%↑ Y/Y)
Canceled cashflow
$12,764K
Net increase in cash
and cash...
$52,942K
(496.53%↑ Y/Y)
Canceled cashflow
$12,961K
Share repurchase
$9,397K
Share issuance costs
$3,083K
(312.72%↑ Y/Y)
Warrant issuance costs
$284K
(127.20%↑ Y/Y)
Stock-based compensation
expense
$7,559K
(189.73%↑ Y/Y)
Change in fair value of
warrant liabilities
$620K
(-97.17%↓ Y/Y)
Prepaid expenses and
other current assets
-$279K
(-247.62%↓ Y/Y)
Depreciation and
amortization
$240K
(-2.44%↓ Y/Y)
Share of earnings
(loss) of joint venture
-$37K
Unrealized loss on foreign
currency remeasurement
-$15K
(94.90%↑ Y/Y)
Net cash used in
operating activities
-$12,867K
(-2.83%↓ Y/Y)
Net cash used in
investing activities
-$94K
(-1075.00%↓ Y/Y)
Canceled cashflow
$8,750K
Net loss
-$19,302K
(58.83%↑ Y/Y)
Investment of joint venture
$84K
Purchase of property,
plant and equipment
$10K
(25.00%↑ Y/Y)
Trade and other
payables
-$2,073K
(-249.68%↓ Y/Y)
R&d tax incentive
receivable
$242K
(104.34%↑ Y/Y)
Buy us a coffee
Incannex Healthcare Inc. (IXHL)
Incannex Healthcare Inc. (IXHL)